M. Cicalese

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M P Cicalese, Maria P. Cicalese, Maria Cicalese, Maria P Cicalese, Maria Pia Cicalese, M. P. Cicalese, Maria-pia Cicalese, M Cicalese
Publication record
134 papers · 5,936 citations · H-index 32

PAPERS

Editorial: Follicular helper T cells in immunity and autoimmunity, volume II.
20260 citationsauthor #3
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy.
202510 citationsauthor #48
Longitudinal Outcomes in Adenosine Deaminase–Deficient SCID With Transplant: Case Series Highlighting Diverse Clinical Outcomes in a Child and Two Adults
20250 citationsauthor #5
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)
20250 citationsauthor #19
Etuvetidigene autotemcel for the treatment of Wiskott-Aldrich Syndrome
20250 citationsauthor #38
Lentiviral hematopoietic stem and progenitor cell gene therapy with Etuvetidigene autotemcel for the treatment of Wiskott-Aldrich Syndrome
20250 citationsauthor #34
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2
20251 citationsauthor #23
Lentiviral hematopoietic stem and progenitor cell gene therapy for Wiskott-Aldrich Syndrome: Early access experience in Italian patients based on 648/1996 law
20250 citationsauthor #24
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for the diagnosis of inborn errors of immunity (IEI).
20241 citationsauthor #9
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
202418 citationsauthor #54
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase
20241 citationsauthor #20
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
202410 citationsauthor #22
Interleukin-1 blockade in patients with Wiskott-Aldrich Syndrome: a retrospective multinational case series.
20246 citationsauthor #2
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID
202420 citationsauthor #2
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity
20245 citationsauthor #25
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities
20242 citationsauthor #26
Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis
202413 citationsauthor #30
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
20235 citationsauthor #13
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
20234 citationsauthor #28
Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy
202314 citationsauthor #18
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit
20231 citationsauthor #5
Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
20234 citationsauthor #23
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
2022182 citationsauthor #41
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency
20225 citationsauthor #2
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
202234 citationsauthor #27
SARS‐CoV‐2 infection and treatment in a cohort of patients with inborn errors of immunity
20225 citationsauthor #12
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report
20224 citationsauthor #23
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
20220 citationsauthor #23
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease
20221 citationsauthor #8
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature
20226 citationsauthor #16
S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
20220 citationsauthor #4
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response
202215 citationsauthor #1
Unveiling the Biological Role of Peripheral Blood Human Circulating Hematopoietic Stem and Progenitor Cells
20220 citationsauthor #27
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
20228 citationsauthor #2
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.
2021105 citationsauthor #20
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
202110 citationsauthor #4
Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Metachromatic Leukodystrophy (MLD): Clinical Outcomes from 38 Patients
20210 citationsauthor #12
Correction to: A Case of Two Adult Brothers with Wiskott‑Aldrich Syndrome, One Treated with Gene Therapy and One with HLA‑Identical Hematopoietic Stem Cell Transplantation
20210 citationsauthor #4
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
202113 citationsauthor #22
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
202139 citationsauthor #8
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
202175 citationsauthor #32
CXCR5‐CXCL13 axis markers in full‐term and preterm human neonates in the first weeks of life
20213 citationsauthor #8
Lentiviral haematopoietic stem cell gene therapy for metachromatic leukodystrophy: Results in nine patients treated with a cryopreserved formulation of OTL-200
20212 citationsauthor #7
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
202155 citationsauthor #23
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency.
202123 citationsauthor #23
Lentiviral hematopoietic stem and progenitor cell gene therapy provides durable clinical benefit in early-symptomatic early-juvenile metachromatic leukodystrophy
20213 citationsauthor #6
Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency
20212 citationsauthor #17
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity
202130 citationsauthor #10
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome
20218 citationsauthor #11
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease.
202111 citationsauthor #5
Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes
202120 citationsauthor #8
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
20210 citationsauthor #27
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
202110 citationsauthor #53
Correction to: A Case of Two Adult Brothers with Wiskott‑Aldrich Syndrome, One Treated with Gene Therapy and One with HLA‑Identical Hematopoietic Stem Cell Transplantation
20213 citationsauthor #4
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
202011 citationsauthor #30
Editorial: Follicular Helper T Cells in Immunity and Autoimmunity
202014 citationsauthor #1
New perspectives in gene therapy for inherited disorders
202010 citationsauthor #1
Urogenital Abnormalities in Adenosine Deaminase Deficiency
20208 citationsauthor #4
A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome
202013 citationsauthor #12
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
202016 citationsauthor #22
Consensus of the Italian Primary Immunodeficiency Network on Transition Management from Pediatric to Adult Care in Patients Affected with Childhood Onset Inborn Errors of Immunity.
202016 citationsauthor #26
T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation
20200 citationsauthor #2
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy
202016 citationsauthor #3
Urogenital Abnormalities in Adenosine Deaminase Deficiency
20200 citationsauthor #4
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic
202020 citationsauthor #8
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency.
201988 citationsauthor #2
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
201951 citationsauthor #7
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
201949 citationsauthor #7
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
2019168 citationsauthor #2
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy
201910 citationsauthor #32
Treatment with Rapamycin Can Restore Regulatory T Cell Function in IPEX Patients.
201950 citationsauthor #21
Lentiviral haematopoietic stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD): Preliminary results from a clinical trial with a cryopreserved formulation of OTL-200
20191 citationsauthor #13
Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network
201933 citationsauthor #26
Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010
20196 citationsauthor #2
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation
201940 citationsauthor #12
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184.
20196 citationsauthor #7
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
20197 citationsauthor #7
NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential.
201916 citationsauthor #11
Efficacy of the Andresen activator before peak growth in class II patients.
20191 citationsauthor #16
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
2019203 citationsauthor #3
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency.
201899 citationsauthor #3
Iconography : Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome
20180 citationsauthor #11
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
201812 citationsauthor #9
Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans
2018103 citationsauthor #8
Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID
201832 citationsauthor #11
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
201826 citationsauthor #17
Gene Therapy for Primary Immunodeficiencies
20180 citationsauthor #1
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety
201855 citationsauthor #1
Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott‐Aldrich syndrome
201825 citationsauthor #11
ALPS-lile phenothype due to ADA2 deficiency rescued by allogeneic stem cell transplantation
20180 citationsauthor #14
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis
201813 citationsauthor #25
Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report
201821 citationsauthor #1
NADPH Oxidase Deficiency: A Multisystem Approach
201735 citationsauthor #2
Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous Hematopoietic Stem Cells Genetically Modified with GLOBE Lentiviral Vector
201717 citationsauthor #2
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers
201744 citationsauthor #10
Beta2 integrins are required for follicular helper T cell differentiation in humans.
20173 citationsauthor #5
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
2016417 citationsauthor #18
Clonal tracking of engineered human hematopoiesis through integration sites analysis
20160 citationsauthor #10
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
201624 citationsauthor #4
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
2016204 citationsauthor #1

TIMELINE

2007 0 citations

2008 2 citations

2009 32 citations

2010 39 citations

2011 13 citations

2012 1 citations

2013 2,298 citations

2014 184 citations

2015 309 citations

2016 942 citations

2017 99 citations

2018 386 citations

2019 729 citations

2020 124 citations

2021 412 citations

2022 260 citations

2023 28 citations

2024 76 citations

2025 11 citations

2026 0 citations

Unknown 0 citations

M. Cicalese

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT